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ABSTRACT
Background: Laparoscopic cholecystectomy for gallblad-
der disease is a common surgical procedure performed in
hospitals throughout the world. This study evaluates the
major factors that contribute to postoperative length of
stay for patients undergoing laparoscopic cholecystec-
tomy.
Methods: We analyzed data for patients undergoing lapa-
roscopic cholecystectomy in a 5-hospital community
health system from December 1, 2008 to January 31, 2009.
The natural logarithm of postoperative length of stay was
modeled to evaluate significant factors and contributions.
Results: Included in the analysis were 232 patients. Three
preoperative patient factors were significant contributors:
body mass index was associated with decreased postop-
erative length of stay, while white blood cell count and the
presence of biliary pancreatitis were associated with in-
creased postoperative length of stay. The operative factors
of fluids administered and ASA class were significant con-
tributors to increased postoperative length of stay, with an
increasing contribution with a higher ASA class. The uti-
lization factor of nonelective status was a significant con-
tributor to increased postoperative length of stay.
Conclusion: Several factors were major contributors to
postoperative length of stay, with ASA class and nonelec-
tive status having the most significant increased contribu-
tion. Efforts to optimize efficient elective care delivery for
patients with symptomatic gallbladder disease may dem-
onstrate a benefit of decreased hospital utilization.
Key Words: Laparoscopic Cholecystectomy, Length of
Stay, Utilization.
INTRODUCTION
Laparoscopic cholecystectomy has become the preferred
procedure for cholelithiasis-related disease.1–6 Popula-
tion-based studies have found that the rate of cholecys-
tectomy has increased since the introduction of the lapa-
roscopic approach.7,8 Given this ubiquity, hospital
utilization for laparoscopic cholecystectomy is an impor-
tant area for study to better manage the care for patients
requiring intervention for symptomatic gallbladder dis-
ease.
Results have been disparate when differences in hospital
length of stay between laparoscopic and traditional small
incision cholecystectomy have been analyzed, as well as
when costs and charges between the 2 have been com-
pared.9–18 Several studies have demonstrated a shorter
hospital stay but longer operative time for laparoscopic
cholecystectomy compared with traditional small incision
cholecystectomy.9–17 However, Keus and colleagues18
found in their analysis that there was no statistical differ-
ence in hospital stay between these groups. When exam-
ining early versus delayed laparoscopic cholecystectomy,
several studies have demonstrated a decreased hospital
stay with early laparoscopic cholecystectomy.19,20
The differing results for hospital length of stay and cost/
charge analysis suggest that there is a need for better
understanding of the relationship between hospital length
of stay and cholecystectomy. The focus of this article is to
better characterize the components that are contributing
factors and their relative influence on postoperative length
of stay.
METHODS
This study was conducted by retrospective review of pa-
tients undergoing elective and nonelective cholecystec-
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SCIENTIFIC PAPERtomy in a 5-hospital community health system in San
Antonio, Texas. Using the data collected by retrospective
review, we modeled postoperative length of stay to better
characterize its contributing factors.
The inclusion criteria for patients for this study were all
adult patients (age 18) undergoing laparoscopic chole-
cystectomy at any of the 5 hospitals from December 2008
through January 2009. The exclusion criterion for this
study was incomplete chart documentation.
Specific data were collected to model postoperative
length of stay. The specific factors and cohort values are
shown in Tables 1, 2, and 3. These factors include pre-
operative patient factors such as patient characteristics
and admission data, operative factors such as operative
type and duration, and utilization factors such as time
from registration to operation and elective status. These
factors were chosen, because they are commonly associ-
ated with the pathophysiology and/or treatment of gall-
bladder disease.
It is important to note that 2 utilization outcomes were
defined in the following manner. Time from registration to
operation was defined as the time from registration to oper-
ative start. Postoperative length of stay (POLOS) was defined
as the time from operative end to discharge from the hospital.
The modeling of postoperative length of stay was per-
formed using the natural logarithm of postoperative
length of stay as a better fit. The natural POLOS logarithm
was chosen because the data were skewed and bounded
by zero (ie, no patient can have a POLOS 0). Regression
models assume that the residuals (defined as the predicted
value minus the actual value of an observation) are nor-
mally distributed. This assumption is often violated when
the data are skewed and bounded. To ameliorate this
violation of assumptions, the natural POLOS logarithm
was chosen. This removes the bounding and causes
skewed data to have a distribution that is close to a normal
distribution. The last fact translates to the residuals be-
coming more normal in their distribution and allowing for
more accurate modeling.
Moreover, it is important to explain the method of mod-
eling using the natural logarithm of postoperative length
Table 1.
Preoperative Patient Factors Evaluated in Model with
Cohort Values
Preoperative Patient Factors n232
Average (SD) age (years) 50.9 (19.4)
Men (n,%) 76 (32.8)
Average (SD) BMI (kg/m
2) 30.3 (7.4)
Diabetes (n,%) 50 (21.6)
Hypertension (n,%) 92 (39.7)
Median (IQR) time to presentation (days) 4 (1, 60)
Mean (SD) admission temperature (°F) 97.8 (0.9)
Mean (SD) admission WBC (k/L) 10.1 (5)
Median (IQR) admission total bilirubin (mg/dL) 0.8 (0.6, 1.2)
Biliary pancreatitis on admission (n, %) 15 (6.5)
Table 2.
Operative Factors Evaluated in Model with Cohort Values
Operative Factors n232
Mean (SD) operative duration (min) 47 (26.2)
ASA
a 1 (%) 35 (15.1)
ASA
a 2 (%) 113 (48.7)
ASA
a 3 (%) 78 (33.6)
ASA
a 4 (%) 6 (2.6)
Anesthesia Start Time
0700–1459 (%) 194 (83.6)
1500–1859 (%) 33 (14.2)
1900–0659 (%) 5 (2.2)
Operative Type
Laparoscopic cholecystectomy Only (%) 54 (23.3)
Laparoscopic cholecystectomy with
Intraoperative cholangiogram (%)
160 (69)
Laparoscopic cholecystectomy with other
abdominal procedure (%)
18 (7.8)
aASA ClassAmerican Society of Anesthesiologists classification.
Table 3.
Utilization Factors Evaluated in Model with Cohort Values
Utilization and Postoperative Factors n232
Elective (n, %) 113 (48.7)
Non-elective (n,%) 119 (51.3)
Median (IQR) time from registration
to operation
0.2 (0.1, 1.2)
Preoperative ERCP (%) 9 (3.9)
Postoperative ERCP (%) 7 (3.0)
Median (IQR) postoperative length
of stay (days)
0.7 (0.6, 1.3)
Mortality (n,%) 0 (0)
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was created using all of the factors that are shown in
Tables 1, 2, and 3. Using the iterative process of back-
wards model selection, we started by fitting a model with
all possible factors of interest included. At each iteration,
the factor with the highest P value (ie, that which contrib-
utes least to the prediction of POLOS) was removed from
the consideration and the model refit. This process was
continued until a maximum model fit, as measured by
AIC, was reached.
By this process, the best fit model for POLOS is shown in
Table 4 with contributing factors and associated coeffi-
cients. Categorical contributing factors in this model, such
as biliary pancreatitis on admission or American Society of
Anesthesiologists (ASA) classifications are presented with
their associated contributing factor. Continuous contribut-
ing factors in this model, such as white blood cell count
and fluids administered, are presented with their base
associated contributing factor. To determine the contribu-
tion of continuous variables, the base associated contrib-
uting factor is raised to the value for each patient. For
example, the base contributing factor for white blood cell
count is raised to the value of the white blood cell count
for a subject to determine the white blood cell count
contribution to POLOS.
RESULTS
Included in the analysis were 232 subjects who met inclu-
sion criteria. As stated before, Table 1, 2, and 3 demon-
strate the preoperative patient, operative, and utilization
factors for the study cohort that was modeled.
Specific focus should be placed on the following factors.
First, there was a near equal distribution of nonelective
cases and elective cases within the cohort, which allowed
for a balanced evaluation of POLOS based on the acute
and chronic manner in which gallbladder disease affects
patients. Next, the median time from registration to the
start of operation was 0.2 days (4.8 hours) with an inter-
quartile range of 0.1 to 1.2 days (2.4 to 28.8 hours). Lastly,
the median postoperative length of stay for the group was
0.7 days with an interquartile range of 0.6 to 1.3 days.
The best fitting model for describing postoperative length
of stay demonstrated 6 contributing factors that were sig-
nificant (Table 4).
In terms of preoperative patient factors, biliary pancreatitis
on admission, admission body mass index, and admission
white blood cell count contribute to postoperative length
of stay. The most significant preoperative patient factor
that contributes to POLOS is biliary pancreatitis on admis-
sion, which has an odds ratio of 1.75 (CI, 1.51 to 2.02).
Stated another way, patients with biliary pancreatitis on
admission have a 75% increased POLOS compared with
similar patients without biliary pancreatitis on admission.
Next, white blood cell count per unit of k/L also in-
creases POLOS and has an odds ratio of 1.02 (CI, 1.01 to
1.03). Because white blood cell count is a continuous
variable, the effect is compounded with increasing leuko-
cytosis. Lastly, body mass index has an odds ratio of 0.98
(CI, 0.98 to 0.99) that corresponds to a slightly decreased
postoperative length of stay per unit of kg/m
2. As with
white blood cell count, this effect is compounded with
increasing body mass index. In terms of operative factors,
ASA and fluids administered in the operative room con-
tributed to the best fit model. ASA3 has an odds ratio of
1.51 (CI, 1.34 to 1.7), and ASA4 has an odds ratio of 2.02
(CI, 1.59 to 2.56) compared to ASA1. This corresponds to
an increased postoperative length of stay for patients
classified as ASA3 of 51% and ASA4 of 102%, respectively,
compared to patients classified as ASA1; an ASA2 classifi-
cation does not contribute any more to POLOS compared
to ASA1. Lastly, fluids administered in the operating room
had an odds ratio of 1.0003 (CI, 1.0002 to 1.0003). This
corresponds to an increase in postoperative length of
stay per milliliter administered with a compounded
Table 4.
Best Fit Model of Contributing Factors to POLOS with
Multiplier Estimates (n232)
Odds Ratio (95% CI) P Value
Baseline POLOS in Model
(Intercept)
2.14 (1.69, 2.72) days
Preoperative Patient Factors
BMI (kg/m
2) 0.98 (0.98, 0.99) 0.001
White Blood Cell Count
(k/L)
1.02 (1.01, 1.03) 0.047
Biliary Pancreatitis on
Admission
1.75 (1.51, 2.02) 0.001
Operative Factors
ASA2 1.17 (1.04, 1.3) 0.168
ASA3 1.51 (1.34, 1.7) 0.001
ASA4 2.02 (1.59, 2.56) 0.004
Fluids Administered (mL) 1.0003 (1.0002, 1.0003) 0.004
Utilization Factors
Nonelective Status 2.27 (2.08, 2.5) 0.001
aASA ClassAmerican Society of Anesthesiologists classification.
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utilization factors, patient status (elective vs nonelec-
tive) contributed to postoperative length of stay. Spe-
cifically, patient status was the strongest contributor to
postoperative length of stay of a nonelective operation
and had an odds ratio of 2.27 (CI, 2.08 to 2.5). A patient
undergoing a nonelective cholecystectomy has a 127%
longer POLOS compared with a similar patient under-
going an elective operation.
DISCUSSION
The primary finding of this study is that patients under-
going laparoscopic cholecystectomy have several factors
that significantly contribute to postoperative length of
stay. The factors that increase postoperative length of stay
include nonelective status, ASA classification, biliary pan-
creatitis, white blood cell count, and fluids administered.
The factor that decreased postoperative length of stay was
BMI. The limitations of this study must be discussed.
These data for modeling were based on a retrospective
chart review, which has inherent limitations of consis-
tency and quality of documentation. Additionally, the re-
view was performed for 2 months, albeit in 5 separate
hospitals, which may have contributed to bias in patient
selection or temporal variability of cholelithiasis-related
disease. Modeling for postoperative length of stay has
inherent limitations as the model is made to fit the data
set in question. This is apparent when examining the
fact that BMI appeared to contribute to a decreased
POLOS, which does not follow many surgeons’ experi-
ences or reports in the literature. Lastly, there were 8
postoperative complications (4 retained common bile
duct stones, 1 case of postoperative biliary pancreatitis,
1 case of gastrointestinal bleeding, 1 cerebrovascular
accident, and 1 bile leak) and no mortalities in the
cohort examined, which did not allow for complica-
tions or mortality to be examined in the model as a
contributing factor, given the low incidence.
CONCLUSION
This study provides an initial descriptive understanding of
the factors that contribute to postoperative length of stay
with estimates on the relative effects of these factors.
Three factors had the highest relative effect in contributing
to increased postoperative length of stay: biliary pancre-
atitis on admission, ASA classes of 3 or 4, and nonelective
status.
Unfortunately for health care delivery organizations, these
high impact factors are often not controllable, because
many patients present to hospitals with comorbid condi-
tions, which contributes to ASA class, and with compli-
cated biliary disease including biliary pancreatitis. It ap-
pears that the most controllable element for such
organizations is nonelective status. There may be a benefit
to hospital utilization by focusing on optimizing elective
laparoscopic cholecystectomy care delivery for patients
with symptomatic gallbladder disease given the large ef-
fect on postoperative length of stay if similar patients
present in a nonelective manner. Continued study needs
to be performed to further evaluate the effects found in
this analysis.
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